MUC16 and ovarian benign neoplasm: Incorporating the relative abundance of specific microbiomes at the genus level with patients’ ages and serum CA-125 levels, we developed a new diagnostic model to differentiate OC from benign ovarian tumors; this model even showed a better diagnostic performance than those without a microbiome biomarker.